Writing Committee consisted of acknowledged experts in hypertrophic cardiomyopathy
(HCM) representing the American College of Cardiology Foundation and the European …

Hypertrophic cardiomyopathy is a complex cardiac disease with unique pathophysiologic
characteristics and a great diversity of morphologic, functional, and clinical features. 1–8 The …

European Heart House, headquarters of the ESC. Any changes in conflict of interest that
arise during the writing period must be notified to the ESC. The Task Force report was …

Background—Dual-chamber pacing (DDD) has been proposed as a treatment alternative to
surgery for severely symptomatic patients with obstructive hypertrophic cardiomyopathy …

Author WJ PAULUS, DL BRUTSAERT, Thierry Gillebert (UGent), FE RADEMAKERS, U
STANISLAS, AF LEITE-MOREIRA, OM HESS, ZH JIANG, P KAUFMANN, L MANDINOV, C …

as nitroglycerin14 and by augmentation of myocardial contractility with drugs such as
digitalis15 and-agonists. 16 On the other hand, outflow obstruction is lessened or even …

Background—Dual-chamber pacing can improve symptoms in hypertrophic cardiomyopathy
(HCM), but the mechanism remains unclear. We hypothesized that pacing generates …

Following a brief introduction on the history and generic codification of the different cardiac
stimulation methods available, the implantation techniques are described and the requisites …

Diastolic dysfunction is common in hypertrophic cardiomyopathy (HC). Previous studies
suggest that Doppler transmitral flow velocity profiles, and the left atrial (LA) M-mode …

Declaração financeira A-Pagamento de qualquer espécie e desde que economicamente
apreciáveis, feitos a (i) você,(ii) ao seu cônjuge/companheiro ou a qualquer outro membro …